IP Library Granted Patent US 9,248,266
Granted Patent B2
US 9,248,266 · App. 14/712,722 · Granted Feb 2, 2016

Method of performing a sphenopalatine ganglion block procedure

Inventors: Stephen W. Chandler (Montgomery, AL); David W. Sanso (Morrison, CO)
Assignee: Biovision Technologies, LLC
A61M31/00A61B1/00135A61B1/06A61B17/24A61M25/10182A61M25/1002A61M25/1011A61M2025/1052A61M2202/048A61M2210/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,248,266
App. No.
14/712,722
Granted
Feb 2, 2016
Kind
B2
Abstract

Methods and devices to quickly and accurately locate the sphenopalatine ganglion (SPG) while performing a sphenopalatine ganglion block procedure that introduces a medication to the SPG. The methods and devices also prevent the medication applied to the SPG from flowing down a patient's throat during the procedure.

Claims (28)

1. A method for delivering a medication to a sphenopalatine ganglion of a patient, the method comprising the steps of:

(a) inserting a portion of a device into a nasal cavity of a patient through a nostril, the device comprising:

a handle comprising a proximal end and a distal end;

an inflation device at least partially and integrally disposed within the handle;

a flexible tubular member extending from the distal end of the handle, the flexible tubular member comprising a proximal end, a distal end, an inflation lumen coupled to the inflation device and extending from the proximal end of the flexible tubular member, and a second lumen extending from the proximal end of the flexible tubular member to a medication port;

an expandable member attached to the flexible tubular member, the expandable member comprising a proximal end and a distal end, wherein the inflation lumen opens, via an inflation port, into the expandable member, wherein the medication port is disposed proximally of the proximal end of the expandable member;

an illumination device disposed distally of the expandable member; and

a non-inflatable stabilizer slidably coupled to the flexible tubular member, wherein the non-inflatable stabilizer is capable of sliding along the flexible tubular member between the handle and the expandable member;

(b) activating the illumination device and viewing light emitted from the illumination device through a portion of the patient's soft palate;

(c) expanding, using the inflation lumen, the expandable member adjacent to the patient's choana;

(d) sliding the non-inflatable stabilizer toward the patient's nose;

(e) introducing an amount of medication into the nasal cavity through the medication port, such that the medication rises to a level and contacts at least a portion of mucosa overlaying a sphenopalatine ganglion of the patient for a period of 5 minutes to 35 minutes;

(f) collapsing the expandable member; and

(g) removing the device from the nasal cavity.

2. The method of claim 1 , further comprising the step of sliding the non-inflatable stabilizer away from the patient's nose.

3. The method of claim 1 , further comprising the step of removing at least a portion of the medication through the medication port in the flexible tubular member.

4. The method of claim 1 , further comprising the step of inserting the device into a second portion of the nasal cavity of the patient through a second nostril and performing steps (b) through (g).

5. The method of claim 1 , wherein the level of medication is maintained for 10 minutes to 30 minutes.

6. The method of claim 5 , wherein the level of medication is maintained for 15 minutes to 25 minutes.

7. The method of claim 6 , wherein the level of medication is maintained for at least 20 minutes.

8. The method of claim 1 , wherein the amount of the medication introduced to the nasal cavity is between 2 milliliters to 15 milliliters.

9. The method of claim 1 , wherein the amount of the medication introduced to the nasal cavity is between 5 milliliters to 10 milliliters.

10. The method of claim 1 , wherein the step of inserting the device into the nasal cavity comprises introducing the device into a channel below an inferior turbinate and above a hard palate.

11. The method of claim 1 , wherein the step of expanding the expandable member adjacent to the patient's choana comprises placing the expandable member in the patient's nasopharynx.

12. The method of claim 1 , wherein the step of introducing an amount of medication into the nasal cavity comprises actuating an auxiliary syringe coupled to the second lumen.

13. The method of claim 1 , wherein the non-inflatable stabilizer comprises a lumen capable of having a first configuration and a second configuration.

14. The method of claim 1 , wherein the non-inflatable stabilizer is capable of sliding along the flexible tubular member when the lumen has a first configuration and the non-inflatable stabilizer is less capable of sliding along the flexible tubular member when the lumen has a second configuration.

15. The method of claim 1 , wherein the handle further comprises a switch for activating the illumination device.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2025
From: BIOVISION TECHNOLOGIES LLC
To: BIOVISION HOLDINGS LLC
Reel/Frame 071171/0030 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: CHANDLER, STEPHEN
To: VALENT MEDICAL, INC.
Reel/Frame 068796/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: SANSO, DAVID
To: VALENT MEDICAL, INC.
Reel/Frame 068797/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: BIOVISION HOLDINGS, LLC
To: VALENT MEDICAL, INC.
Reel/Frame 068799/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2015
From: CHANDLER, STEPHEN W.; SANSO, DAVID W.
To: BIOVISION TECHNOLOGIES, LLC
Reel/Frame 037327/0911 →
Continuity (5)
Continuation 14699999 · Apr 29, 2015
Continuation In Part 14572353 · Dec 16, 2014
Continuation In Part 14298521 · Jun 6, 2014
Provisional Application 61917097 · Dec 17, 2013
Related Publication 20150258315A1 · Sep 17, 2015